Working… Menu

Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03610646
Recruitment Status : Recruiting
First Posted : August 1, 2018
Last Update Posted : May 15, 2019
Momenta Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Mylan Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 28, 2020
Estimated Study Completion Date : December 21, 2020